Trending Topic

bullous pemphigoid
2 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

  The FDA approval of dupilumab represents a major step forward for adults living with bullous pemphigoid (BP), one that is likely to transform how we manage this chronic autoimmune blistering condition. The FDA approval of dupilumab represents a major step forward for adults living with bullous pemphigoid (BP), one that is likely to transform […]

Select Specialty or Clinical Area

touchDERMATOLOGY touchDERMATOLOGY

Register Now!

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

  • Save your progress for video
  • Keep track of your CME credits
  • Add personalised learning notes
  • Receive updates from course leaders and faculty
  • Be the first to hear about new and exciting interactive learning opportunities
Close Popup